{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:33:26Z","timestamp":1761989606174,"version":"3.40.5"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0009446","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T18:10:15Z","timestamp":1622571015000},"page":"e0009446","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ivermectin as a potential treatment for COVID-19?"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-4310","authenticated-orcid":true,"given":"Olivier","family":"Chosidow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Bernigaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Lespine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Changeux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lecuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"pntd.0009446.ref001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"pntd.0009446.ref002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.26102","article-title":"Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis","volume":"96","author":"ML Meizlish","year":"2021","journal-title":"Am J Hematol"},{"key":"pntd.0009446.ref003","article-title":"Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine","author":"M Levine-Tiefenbrun","year":"2021","journal-title":"Nat Med"},{"key":"pntd.0009446.ref004","doi-asserted-by":"crossref","first-page":"e0248132","DOI":"10.1371\/journal.pone.0248132","article-title":"Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)","volume":"16","author":"S Juul","year":"2021","journal-title":"PLoS One"},{"key":"pntd.0009446.ref005","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"L Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"pntd.0009446.ref006","first-page":"1426","article-title":"Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19","volume":"325","author":"E Lopez-Medina","year":"2021","journal-title":"A randomized clinical trial. JAMA"},{"key":"pntd.0009446.ref007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.18788","article-title":"Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies","volume":"182","author":"R Morris-Jones","year":"2020","journal-title":"Br J Dermatol"},{"key":"pntd.0009446.ref008","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.14202\/vetworld.2019.1204-1211","article-title":"Current therapeutic applications and pharmacokinetic modulations of ivermectin","volume":"12","author":"K Sharun","year":"2019","journal-title":"Vet World."},{"key":"pntd.0009446.ref009","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"CA Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"pntd.0009446.ref010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa0905471","article-title":"Oral ivermectin versus malathion lotion for difficult-to-treat head lice","volume":"362","author":"O Chosidow","year":"2010","journal-title":"N Engl J Med"},{"key":"pntd.0009446.ref011","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJMc2100217","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"A Lundh","year":"2021","journal-title":"N Engl J Med"},{"key":"pntd.0009446.ref012","first-page":"10.1111\/bjd.19821","article-title":"Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality","volume":"16","author":"C Bernigaud","year":"2021","journal-title":"Br J Dermatol"},{"journal-title":"BioRxiv","article-title":"Anti-COVID-19 efficacy of ivermectin in the golden hamster","author":"GD De Melo","key":"pntd.0009446.ref013"},{"key":"pntd.0009446.ref014","doi-asserted-by":"crossref","first-page":"100720","DOI":"10.1016\/j.eclinm.2020.100720","article-title":"The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial","volume":"32","author":"C Chaccour","year":"2021","journal-title":"EClinicalMedicine"},{"journal-title":"Research Square","article-title":"Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis","author":"A Bryant","key":"pntd.0009446.ref015"},{"key":"pntd.0009446.ref016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/mol.53.2.283","article-title":"Ivermectin: A Positive Allosteric Effector of the a7 Neuronal Nicotinic Acetylcholine Receptor","volume":"53","author":"RM Krause","year":"1998","journal-title":"Mol Pharmacol"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T18:10:27Z","timestamp":1622571027000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009446"}},"subtitle":[],"editor":[{"given":"Paul J.","family":"Brindley","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009446","relation":{},"ISSN":["1935-2735"],"issn-type":[{"type":"electronic","value":"1935-2735"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}